Abstract
As the available in vitro and in vivo data suggest that interleukin (IL)-4 and IL-10 have immunosuppressive activity, our hypothesis was that serum IL-4 and IL-10 levels would correlate inversely with parameters of inflammation in patients with inflammatory arthritis. IL-4 was detected in the serum of 12 out of 140 patients with rheumatoid arthritis (RA), which was increased compared to the proportion found with patients with osteoarthritis (OA; P< 0.02). In addition, IL-4 was detected in the serum of 2 of 19 patients with systemic lupus erythematosus (SLE), 2 of 24 patients with psoriatic arthritis and 1 of 5 patients with Behçet's syndrome. No IL-4 was detected in patients with the following conditions: OA (58 patients), gout (17 patients), ankylosing spondylitis (6 patients), Reiter's syndrome (6 patients), polymyalgia rheumatica (6 patients), temporal arteritis (5 patients) and scleroderma (3 patients). No IL-10 was detected in any of the sera tested. We discuss the possible relevance of these results to the regulation of the immune response evident in inflammatory arthritis.
Similar content being viewed by others
References
Ziff M (1990) Rheumatoid arthritis: its present and future. J Rheumatol 17:127–132
Burmester GR, Dimitriu-Bona A, Waters SJ, Winchester RJ (1983) Identification of three major lining cell populations by monoclonal antibodies directed to Ia antigens associated with monocyte/macrophages and fibroblasts. Scand J Immunol 17:69–82
Brozik M, Rosztsoczy I, Mersetey K, Bsalint G, Gasal M, Balogh Z, Mitszova M, Velics V, Falus A (1992) Interleukin 6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production. J Rheumatol 19:63–68
Houssiau FA, DeVogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:6–8
Hermann E, Fleischer B, Mayet WJ, Poralla T, Meyer zum Buschenfelde KH (1989) Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis. Clin Exp Rheumatol 7:411–414
Holt I, Cooper RG, Hopkins SJ (1991) Relationship between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritic patients. Eur J Invest 21:479–484
Dasgupta B, Corkill M, Kirkham B, Gibson T, Panayi G (1992) Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol 19:22–25
Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86:3803–3807
Briolay J, Dechanet J, Blanchard D, Banchereau J, Miossec P (1992) Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients. J Clin Immunol 12: 36–44
te Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor CG (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α and IL-6 by human monocytes. Blood 76: 1392–1397
Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J (1992) Inhibition of the production of proinflammatory cytokines and immunoglobulins by IL-4 in an ex-vivo model of rheumatoid arthritis. Arthritis Rheum 35: 874–883
Bendrups A, Hilton A, Meager A, Hamilton JA (1993) Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid. Rheumatol Int 12:217–220
Dechanet J, Briolay J, Rissoan M-C, Chomarat P, Galizzi J-P, Banchereau J, Miossec P (1993) IL-4 inhibits growth factorstimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 151:4908–4917
Fiorentino DF, Bond MW, Mossman TR (1989) Two types of mouse helper T cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081–2095
Zlotnik A, Moore KW (1991) Interleukin 10. Cytokine 3:366–371
Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE (1987) B cell stimulatory factor-1/interleukin-4 mRNA is expressed in normal and transformed mast cells. Cell 50:809–818
Howard M, Farraf J, Hilfiker M, Johnson B, Takatsu K, Hamoaka T, Paul WE (1982) Identification of a T-cell derived B cell growth factor distinct from interleukin 2. J Exp Med 155: 914–923
Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ (1993) Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 151:3370–3380
Lee JD, Swisher SG, Minehart EH, McBride WH, Economou JS (1990) Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells. J Leukocyte Biol 47:475–479
Gibbons R, Martinez O, Matli M, Heinzel F, Bernstein M, Warren R (1990) Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro. Lymphokine Res 9: 283–287
Cheung DL, Hart PH, Vitti GF, Whitty GA, Hamilton JA (1990) Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 71:70–75
Donnelly RP, Crofford LJ, Freeman SL, Buras J, Remmers E, Wilder RL, Fenton MJ (1993) Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kB activity in monocytes and fibroblasts. J Immunol 151:5603–5612
Rousset F, Garda E, Defrance T (1992) Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890–1893
Merville P, Rousset F, Banchereau J, Klein B, Bataille R (1992) Serum interleukin 10 in early stage multiple myeloma. Lancet 340:1544–1545
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Assocation 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Byron KA, Varigos G, Wootton A (1992) Hydrocortisone inhibition of human interleukin-4. Immunology 77:624–626
Chen Q, Daniel V, Maher DW, Hersey P (1994) Production of IL-1- by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56:755–760
Linker J III, Williams R Jr (1986) Tests for detection of rheumatoid factors. In: Rose N, Friedman H, Fahey J (eds) Manual of clinical laboratory immunology USA. Library of Congress cataloguing in Publication data, 3rd edn. pp 759–761
Reddy MM, Weissman AM, Mazza DS, Meriney DK, Johns M, Carrabis S, Grieco MH (1992) Circulating elevated levels of soluble CD23, interleukin-4, and CD20+CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann Allergy 69:131–134
Needleman BW, Fredrick M, Wigley M, Stair RW (1992) Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum 35:67–72
Miossec P, Naviliat M, Dupuy-d'Angeac A, Sany J, Banchereau J (1990) Low levels of IL-4 and high levels of transforming growth factor beta in rheumatoid arthritis. Arthritis Rheum 33:1180–1187
Chen E, Keystone EC, Fish EN (1993) Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 36:901–910
Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM (1993) Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151:4344–4351
Wong HL, Lotze MT, Wahl LM, Wahl SM (1992) Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J Immunol 148:2118–2125
Wong HL, Costa GL, Lotze MT, Wahl SM (1993) Interleukin 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J Exp Med 177:775–781
Hamilton JA, Piccoli DS, Cebon J, Layton JE, Rathanaswani P, McColl SR, Leizer T (1992) Cytokine regulation of colonystimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulogy-CSF production. Blood 79:1413–1419
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper cell. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immuno 136:2348–2355
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cicuttini, F.M., Byron, K.A., Maher, D. et al. Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis. Rheumatol Int 14, 201–206 (1995). https://doi.org/10.1007/BF00262298
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262298